These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15734855)

  • 1. Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women.
    Piché ME; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J; Lemieux S
    Diabetes; 2005 Mar; 54(3):770-7. PubMed ID: 15734855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women.
    Piché ME; Lemieux S; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J
    Am J Cardiol; 2005 Jul; 96(1):92-7. PubMed ID: 15979442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional body fat distribution and metabolic profile in postmenopausal women.
    Piché ME; Lapointe A; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J; Lemieux S
    Metabolism; 2008 Aug; 57(8):1101-7. PubMed ID: 18640388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
    Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women?
    Brochu M; Tchernof A; Turner AN; Ades PA; Poehlman ET
    Metabolism; 2003 May; 52(5):599-604. PubMed ID: 12759890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study.
    Brochu M; Mathieu ME; Karelis AD; Doucet E; Lavoie ME; Garrel D; Rabasa-Lhoret R
    Obesity (Silver Spring); 2008 May; 16(5):1085-93. PubMed ID: 18356851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
    dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
    Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between insulin sensitivity and the triglyceride-HDL-C ratio in overweight and obese postmenopausal women: a MONET study.
    Karelis AD; Pasternyk SM; Messier L; St-Pierre DH; Lavoie JM; Garrel D; Rabasa-Lhoret R
    Appl Physiol Nutr Metab; 2007 Dec; 32(6):1089-96. PubMed ID: 18059582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
    Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML
    Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal hypertension, abdominal obesity, apolipoprotein and insulin resistance.
    Ben Ali S; Belfki-Benali H; Ahmed DB; Haddad N; Jmal A; Abdennebi M; Romdhane HB
    Clin Exp Hypertens; 2016; 38(4):370-4. PubMed ID: 27149156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy expenditure from physical activity and the metabolic risk profile at menopause.
    Major GC; Piché ME; Bergeron J; Weisnagel SJ; Nadeau A; Lemieux S
    Med Sci Sports Exerc; 2005 Feb; 37(2):204-12. PubMed ID: 15692314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between circulating free fatty acids, visceral adipose tissue accumulation, and insulin sensitivity in postmenopausal women.
    Lapointe A; Piché ME; Weisnagel SJ; Bergeron J; Lemieux S
    Metabolism; 2009 Feb; 58(2):180-5. PubMed ID: 19154950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women.
    Brochu M; Starling RD; Tchernof A; Matthews DE; Garcia-Rubi E; Poehlman ET
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2378-84. PubMed ID: 10902782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Two Training Modalities on Body Fat and Insulin Resistance in Postmenopausal Women.
    Henríquez S; Monsalves-Alvarez M; Jimenez T; Barrera G; Hirsch S; de la Maza MP; Leiva L; Rodriguez JM; Silva C; Bunout D
    J Strength Cond Res; 2017 Nov; 31(11):2955-2964. PubMed ID: 29065076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.
    Franco C; Brandberg J; Lönn L; Andersson B; Bengtsson BA; Johannsson G
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1466-74. PubMed ID: 15598680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
    Lemieux S; Bédard A; Piché MÈ; Weisnagel SJ; Corneau L; Bergeron J
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress is associated with C-reactive protein in nondiabetic postmenopausal women, independent of obesity and insulin resistance.
    Park S; Kim M; Paik JK; Jang YJ; Lee SH; Lee JH
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):65-70. PubMed ID: 22816656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukins 6 and 8 and abdominal fat depots are distinct correlates of lipid moieties in healthy pre- and postmenopausal women.
    Veldhuis JD; Dyer RB; Trushin SA; Bondar OP; Singh RJ; Klee GG
    Endocrine; 2016 Dec; 54(3):671-680. PubMed ID: 27444747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women.
    Lee SW; Jo HH; Kim MR; You YO; Kim JH
    Gynecol Endocrinol; 2012 Jun; 28(6):472-7. PubMed ID: 22114890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.
    Malita FM; Messier V; Lavoie JM; Bastard JP; Rabasa-Lhoret R; Karelis AD
    Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):173-9. PubMed ID: 19501492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.